Lisa Stiffler

Lisa Stiffler

Reporter at CoMotion News
Northwest United States

Lisa Stiffler is a journalist who covers nonprofits, companies, and researchers applying technology to environmental, energy, health, transit, education and other societal challenges; she has worked at the Seattle Post-Intelligencer, freelanced for The Seattle Times, and written for outlets including Seattle's Child, Sightline Institute, NPR, MSNBC, Smithsonian Magazine, GeekWire and CoMotion News.

Seattle Startup Edo Develops Virtual Power Plant Tech to Turn Commercial Buildings into Grid Assets Amid Rising Demand

Seattle startup Edo has developed technology over five years to transform commercial buildings into virtual power plants, helping utilities manage peak electricity demand amid rising pressures from data centers and extreme weather. Their solution enables buildings to reduce electricity use during high demand and adapt to dynamic pricing, attracting growing interest from utilities and building operators.

Former CrowdStrike and Bloomberg Engineers Raise $2M for Seattle Fintech OpenCFO to Automate Mid-Sized Company Finance

Seattle fintech startup OpenCFO, led by former CrowdStrike and Bloomberg engineers, has raised $2 million to automate financial functions for mid-sized companies by unifying accounts payable, receivable, and treasury. The company launched in December, now employs 15 people, and integrates agentic AI with treasury infrastructure for enhanced financial operations visibility and control.

Seattle Startup Homeostasis Converts Carbon Emissions into Graphite for Batteries, Backed by Saudi Aramco Investment

Seattle-area startup Homeostasis is developing technology to convert captured carbon dioxide into graphite for batteries, aiming to compete with China's dominant supply amid shifting U.S. policies and global trade tensions. The company secured strategic funding from Saudi Aramco's investment arm to scale operations and support Saudi Arabia's domestic EV supply chain ambitions.

TerraPower Receives First U.S. Federal Permit for Next-Gen Nuclear Reactors, Plans Eight Reactors with Meta by 2035

Bill Gates-backed TerraPower became the first company to receive U.S. federal approval to build a next-generation nuclear power plant, with construction permits granted by the Nuclear Regulatory Commission. The company recently signed an agreement with Meta to build up to eight advanced Natrium reactors in the U.S., aiming for the first two to be operational by 2032.

Seattle Startup loanTERRA Launches Solar Financing Platform Partnering with Credit Unions Amid Shrinking Federal Incentives

Seattle startup loanTERRA offers a transparent financing platform connecting credit unions and community banks with vetted solar installers to simplify rooftop solar adoption amid fading federal incentives. Founder Bill Paulen leverages financial experience to create a loan service that supports sustainable solar growth despite reduced tax credits.

Seattle Startup Emerald Battery Labs Raises $1.1M to Scale Sodium-Ion Battery Technology Competing with Chinese Giants CATL and BYD

Seattle-based Emerald Battery Labs raised nearly $1.1 million in a pre-seed round to scale its sodium-ion battery technology, offering a cheaper and safer alternative to lithium-ion batteries. While China leads in sodium-ion battery production through companies like CATL and BYD, U.S. startups are entering the competition amid growing demand for energy storage solutions.

Mitera Biosciences Secures $1.75M to Develop Pregnancy-Inspired Immunotherapies for Autoimmune and Transplant Patients

Mitera Biosciences has emerged from stealth with $1.75 million to develop therapeutics targeting autoimmune diseases and organ transplant rejection, inspired by the immune tolerance mechanisms of pregnancy. The company focuses on a placenta- and thymus-expressed protein to create novel immunotherapies that aim to reduce side effects of current immunosuppressants.

Seattle Startup Pauling.AI Uses AI to Cut Drug Discovery from Months to Weeks, Founded by Ex-Google Exec Javier Tordable in 2024

Seattle startup Pauling.AI uses AI to automate early drug discovery steps, reducing timelines from months to weeks and aiming to greatly increase new drug approvals. Founded in 2024 by former Google technical director Javier Tordable, the company offers a 'scientist-as-a-service' platform to assist researchers with computational chemistry and drug candidate modeling.

Organizations

  • CoMotion News Reporter · current
  • GeekWire Reporter · current

Online